Drug induced liver injury classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Classification== | ==Classification== | ||
Drug induced liver injury | Drug induced liver injury may be classified into multiple subtypes based on clinical presentation, mechanism, or histologic findings. | ||
===Clinical presentation:=== | ===Clinical presentation:=== | ||
====Hepatocellular injury==== | |||
*elevation of serum transaminases > 2-5 times the upper limit of normal | *elevation of serum transaminases > 2-5 times the upper limit of normal | ||
*may have hyperbilirubinemia | *may have hyperbilirubinemia | ||
*may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin) | *may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin) | ||
====Cholestatic injury==== | |||
*elevation of alkaline phosphatase > 3 times the upper limit of normal | *elevation of alkaline phosphatase > 3 times the upper limit of normal | ||
*hyperbilirubinemia | *may have hyperbilirubinemia | ||
*may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin) | *may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin) | ||
====Mixed injury==== | |||
*both alkaline phosphatase and transaminases are elevated in roughly equal proportion, and/or an alanine aminotransferase to alkaline phosphatase ratio between 2-5 | *both alkaline phosphatase and transaminases are elevated in roughly equal proportion, and/or an alanine aminotransferase to alkaline phosphatase ratio between 2-5 | ||
===Mechanism:=== | ===Mechanism:=== | ||
====Dose-dependent hepatotoxicity==== | |||
*e.g. acetaminophen-induced centrilobular necrosis | *e.g. acetaminophen-induced centrilobular necrosis | ||
====Idiosyncratic hepatotoxicity==== | |||
*e.g. stimulation of immune reponse by biologic agents, indepdenetent of dose | *e.g. stimulation of immune reponse by biologic agents, indepdenetent of dose | ||
*e.g. altered host genes involved in drug metabolism | *e.g. altered host genes involved in drug metabolism | ||
===Histologic findings:=== | ===Histologic findings:=== | ||
====Hepatitis (hepatocellular injury)==== | |||
====Cholestasis==== | |||
====Granulomatous==== | |||
====Steatosis==== | |||
====Fibrosis==== | |||
==References== | ==References== | ||
Revision as of 16:32, 5 August 2016
|
Drug induced liver injury Microchapters |
|
Differentiating Drug Induced Liver Injury from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Drug Induced Liver Injury On the Web |
|
American Roentgen Ray Society Images of Drug induced liver injury |
|
Risk calculators and risk factors for Drug induced liver injury |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rachita Navara, M.D. [2]
Overview
There are various classification systems in place for drug induced liver injury.[1]
Classification
Drug induced liver injury may be classified into multiple subtypes based on clinical presentation, mechanism, or histologic findings.
Clinical presentation:
Hepatocellular injury
- elevation of serum transaminases > 2-5 times the upper limit of normal
- may have hyperbilirubinemia
- may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin)
Cholestatic injury
- elevation of alkaline phosphatase > 3 times the upper limit of normal
- may have hyperbilirubinemia
- may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin)
Mixed injury
- both alkaline phosphatase and transaminases are elevated in roughly equal proportion, and/or an alanine aminotransferase to alkaline phosphatase ratio between 2-5
Mechanism:
Dose-dependent hepatotoxicity
- e.g. acetaminophen-induced centrilobular necrosis
Idiosyncratic hepatotoxicity
- e.g. stimulation of immune reponse by biologic agents, indepdenetent of dose
- e.g. altered host genes involved in drug metabolism
Histologic findings:
Hepatitis (hepatocellular injury)
Cholestasis
Granulomatous
Steatosis
Fibrosis
References
- ↑ Fisher K, Vuppalanchi R, Saxena R (2015). "Drug-Induced Liver Injury". Arch Pathol Lab Med. 139 (7): 876–87. doi:10.5858/arpa.2014-0214-RA. PMID 26125428.